Featured Post

A systematic review and meta-analysis: the therapeutic and ... - BMC Gastroenterology

  • Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ. 1992;70(6):705–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yip R, Sharp TW. Acute malnutrition and high childhood mortality related to diarrhea. Lessons from the 1991 Kurdish refugee crisis. JAMA. 1993;270(5):587–90.

    Article  CAS  PubMed  Google Scholar 

  • DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92(11):1962–75.

    CAS  PubMed  Google Scholar 

  • Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H, European Society for Paediatric Gastroenterology, Hepatology, and Nutrition; European Society for Paediatric Infectious Diseases. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2008;46(Suppl 2):S81-122.

    Article  PubMed  Google Scholar 

  • Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H. ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe Expert Working Group. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr. 2008;46(5):619–21.

    Article  PubMed  Google Scholar 

  • Shornikova AV, Casas IA, Mykkänen H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997;16(12):1103–7.

    Article  CAS  PubMed  Google Scholar 

  • Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74(19):6032–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009;11(9):35.

    Article  Google Scholar 

  • Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in Human Health and Diseases. Front Microbiol. 2018;19(9):757.

    Article  Google Scholar 

  • Szymański H, Szajewska H. Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis: a randomized controlled trial. Pediatr Infect Dis J. 2019;38(10):e237–42.

    Article  PubMed  Google Scholar 

  • Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes. 2014;5(3):285–93.

    Article  CAS  PubMed  Google Scholar 

  • Akl EA, Altman DG, Aluko P, Askie LM, Young C. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. New York: John Wiley & Sons; 2019.

    Google Scholar 

  • Maragkoudaki M, Chouliaras G, Moutafi A, Thomas A, Orfanakou A, Papadopoulou A. Efficacy of an oral rehydration solution enriched with Lactobacillus reuteri DSM 17938 and Zinc in the management of Acute Diarrhoea in infants: a randomized, double-blind, placebo-controlled trial. Nutrients. 2018;10(9):1189.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shornikova AV, Casas IA, Isolauri E, Mykkänen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr. 1997;24(4):399–404.

    Article  CAS  PubMed  Google Scholar 

  • Dinleyici EC, Dalgic N, Guven S, Metin O, Yasa O, Kurugol Z, Turel O, Tanir G, Yazar AS, Arica V, Sancar M, Karbuz A, Eren M, Ozen M, Kara A, Vandenplas Y. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J). 2015;91(4):392–6.

    Article  PubMed  Google Scholar 

  • Francavilla R, Lionetti E, Castellaneta S, Ciruzzi F, Indrio F, Masciale A, Fontana C, La Rosa MM, Cavallo L, Francavilla A. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea–a double-blind study. Aliment Pharmacol Ther. 2012;36(4):363–9.

    Article  CAS  PubMed  Google Scholar 

  • Pernica JM, Steenhoff AP, Mokomane M, Moorad B, Lechiile K, Smieja M, Mazhani L, Cheng J, Kelly MS, Loeb M, Stordal K, Goldfarb DM. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: a pilot, randomized, factorial, controlled trial. PLoS One. 2017;12(10): e0185177.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dinleyici EC, PROBAGE Study Group, Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr. 2014;103(7):e300-5.

    PubMed  Google Scholar 

  • Wanke M, Szajewska H. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2012;161(1):40-3.e1.

    Article  PubMed  Google Scholar 

  • Urbańska M, Gieruszczak-Białek D, Szymański H, Szajewska H. Effectiveness of Lactobacillus reuteri DSM 17938 for the prevention of Nosocomial diarrhea in children: a randomized, double-blind Placebo-controlled Trial. Pediatr Infect Dis J. 2016;35(2):142–5.

    Article  PubMed  Google Scholar 

  • Kołodziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial. Clin Microbiol Infect. 2019;25(6):699–704.

    Article  PubMed  Google Scholar 

  • Dinleyici EC, Kara A, Ozen M, Vandenplas Y. Saccharomyces boulardii CNCM I-745 in different clinical conditions. Expert Opin Biol Ther. 2014;14(11):1593–609.

    Article  CAS  PubMed  Google Scholar 

  • Urbańska M, Gieruszczak-Białek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther. 2016;43(10):1025–34.

    Article  PubMed  Google Scholar 

  • Patro-Gołąb B, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for treating acute gastroenteritis in children. An Update Nutrients. 2019;11(11):2762.

    Article  PubMed  Google Scholar 

  • Sagheddu V, Uggeri F, Belogi L, Remollino L, Brun P, Bernabè G, Moretti G, Porzionato A, Morelli L, Castagliuolo I, Elli M. The Biotherapeutic Potential of Lactobacillus reuteri characterized using a target-specific selection process. Front Microbiol. 2020;15(11):532.

    Article  Google Scholar 

  • Schnadower D, Tarr PI, Freedman SB. Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis. Aliment Pharmacol Ther. 2019;50(5):620–2.

    Article  PubMed  Google Scholar 

  • Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics. 2014;134(1):e176–91.

    Article  PubMed  Google Scholar 

  • Padayachee M, Visser J, Viljoen E, Musekiwa A, Blaauw R. Efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the paediatric population: a systematic review. S Afr J Clin Nutr. 2019;32:58–69.

    Google Scholar 

  • Athalye-Jape G, Rao S, Patole S. Lactobacillus reuteri DSM 17938 as a probiotic for preterm neonates: a strain-specific systematic review. JPEN J Parenter Enteral Nutr. 2016;40(6):783–94.

    Article  CAS  PubMed  Google Scholar 

  • Deng Z, Dai T, Zhang W, Zhu J, Luo XM, Fu D, Liu J, Wang H. Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion of Lactobacillus reuteri to Host Mucin to Enhance Probiotic Effects. Int J Mol Sci. 2020;21(24):9756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JN, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, Smith A, Roth B, Polak J, Motala A, Perry T, Shekelle PG. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep). 2011;200:1–645.

    Google Scholar 

  • Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean JM, O'Connell KJ, Mahajan P, Levine AC, Bhatt SR, Roskind CG, Powell EC, Rogers AJ, Vance C, Sapien RE, Olsen CS, Metheney M, Dickey VP, Hall-Moore C, Freedman SB. Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children. N Engl J Med. 2018;379(21):2002–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Freedman SB, Williamson-Urquhart S, Farion KJ, Gouin S, Willan AR, Poonai N, Hurley K, Sherman PM, Finkelstein Y, Lee BE, Pang XL, Chui L, Schnadower D, Xie J, Gorelick M, Schuh S, PERC PROGUT Trial Group. Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis. N Engl J Med. 2018;379(21):2015–26.

    Article  CAS  PubMed  Google Scholar 

  • Comments

    Popular Posts

    Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University

    Model Monday's: Diana Moldovan

    Navel Orangeworm Plague Might be Growing Out of Control - Growing Produce